부산대학교 도서관

ABSTRACTListeria monocytogeneshas been exploited previously as a vaccine vector for the delivery of heterologous proteins such as tumor-specific antigens for active cancer immunotherapy. However, for effective use of live vector in clinics, safety is a major concern. In the present study, we describe an irreversibly attenuated and highly immunogenic L. monocytogenesplatform, the L. monocytogenes dal-, dat-, and actA-deleted strain that expresses the human prostate-specific antigen (PSA) using an antibiotic resistance marker-free plasmid (the dal dat?actA142 strain expressing PSA). Despite limited in vivo survival, the dal dat?actA142 strain was able to elicit efficient immune responses required for tumor clearance. Our results showed that immunization of mice with the dal dat?actA142 strain caused the regression of the tumors established by the prostate adenocarcinoma cell line expressing PSA. An evaluation of immunologic potency indicated that the dal dat?actA142 strain elicits a high frequency of PSA-specific immune responses. Interestingly, immunization with the dal dat?actA142 strain induced significant infiltration of PSA-specific T cells in the intratumoral milieu. Collectively, our data suggest that the dal dat?actA142 strain is a safe and potent vector for clinical use and that this platform may be further exploited as a potential candidate to express other single or multiple antigens for cancer immunotherapy.